154 related articles for article (PubMed ID: 17300445)
1. Vaccine protection against feline immunodeficiency virus: setting the challenge.
Hosie MJ; Beatty JA
Aust Vet J; 2007; 85(1-2):5-12; quiz 85. PubMed ID: 17300445
[TBL] [Abstract][Full Text] [Related]
2. Vaccine protection against feline immunodeficiency virus: setting the challenge.
Zwijnenberg R; Yamamoto JK
Aust Vet J; 2007 Jun; 85(6):210-1. PubMed ID: 17547630
[No Abstract] [Full Text] [Related]
3. The development of a vaccine against feline immunodeficiency virus.
Hosie MJ
Br Vet J; 1994; 150(1):25-39. PubMed ID: 8025833
[TBL] [Abstract][Full Text] [Related]
4. Experimental vaccine protection against feline immunodeficiency virus.
Yamamoto JK; Okuda T; Ackley CD; Louie H; Pembroke E; Zochlinski H; Munn RJ; Gardner MB
AIDS Res Hum Retroviruses; 1991 Nov; 7(11):911-22. PubMed ID: 1662057
[TBL] [Abstract][Full Text] [Related]
5. Vaccination against the feline immunodeficiency virus: the road not taken.
Lecollinet S; Richardson J
Comp Immunol Microbiol Infect Dis; 2008 Mar; 31(2-3):167-90. PubMed ID: 17706778
[TBL] [Abstract][Full Text] [Related]
6. New vaccine to fight feline FIV.
Aust Vet J; 2004 Dec; 82(12):730. PubMed ID: 15648930
[No Abstract] [Full Text] [Related]
7. Vaccination of cats against feline immunodeficiency virus (FIV): a matter of challenge.
Hesselink W; Sondermeijer P; Pouwels H; Verblakt E; Dhore C
Vet Microbiol; 1999 Sep; 69(1-2):109-10. PubMed ID: 10515278
[TBL] [Abstract][Full Text] [Related]
8. Lack of protection against feline immunodeficiency virus infection among domestic cats in New Zealand vaccinated with the Fel-O-Vax® FIV vaccine.
Stickney A; Ghosh S; Cave NJ; Dunowska M
Vet Microbiol; 2020 Nov; 250():108865. PubMed ID: 33045631
[TBL] [Abstract][Full Text] [Related]
9. Vaccination of cats with attenuated feline immunodeficiency virus proviral DNA vaccine expressing gamma interferon.
Gupta S; Leutenegger CM; Dean GA; Steckbeck JD; Cole KS; Sparger EE
J Virol; 2007 Jan; 81(2):465-73. PubMed ID: 17079309
[TBL] [Abstract][Full Text] [Related]
10. Vaccination with fixed feline immunodeficiency virus (FIV) infected cells: protection, breakthrough and specificity of response.
Bishop SA; Stokes CR; Gruffydd-Jones TJ; Whiting CV; Humphries JE; Osborne R; Papanastasopoulou M; Harbour DA
Vaccine; 1996 Sep; 14(13):1243-50. PubMed ID: 8961513
[TBL] [Abstract][Full Text] [Related]
11. Efficacy evaluation of prime-boost protocol: canarypoxvirus-based feline immunodeficiency virus (FIV) vaccine and inactivated FIV-infected cell vaccine against heterologous FIV challenge in cats.
Tellier MC; Pu R; Pollock D; Vitsky A; Tartaglia J; Paoletti E; Yamamoto JK
AIDS; 1998 Jan; 12(1):11-8. PubMed ID: 9456250
[TBL] [Abstract][Full Text] [Related]
12. Vaccine protection against feline immunodeficiency virus.
Hosie MJ; Beatty JA
Aust Vet J; 2007 Aug; 85(8):302-3. PubMed ID: 17685973
[No Abstract] [Full Text] [Related]
13. Neutralising antibody response in domestic cats immunised with a commercial feline immunodeficiency virus (FIV) vaccine.
Bęczkowski PM; Harris M; Techakriengkrai N; Beatty JA; Willett BJ; Hosie MJ
Vaccine; 2015 Feb; 33(8):977-84. PubMed ID: 25613718
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of a feline immunodeficiency virus vaccine.
Huang C; Conlee D; Loop J; Champ D; Gill M; Chu HJ
Anim Health Res Rev; 2004 Dec; 5(2):295-300. PubMed ID: 15984343
[TBL] [Abstract][Full Text] [Related]
15. An initial examination of the potential role of T-cell immunity in protection against feline immunodeficiency virus (FIV) infection.
Aranyos AM; Roff SR; Pu R; Owen JL; Coleman JK; Yamamoto JK
Vaccine; 2016 Mar; 34(12):1480-8. PubMed ID: 26802606
[TBL] [Abstract][Full Text] [Related]
16. Passive antibody protection of cats against feline immunodeficiency virus infection.
Hohdatsu T; Pu R; Torres BA; Trujillo S; Gardner MB; Yamamoto JK
J Virol; 1993 Apr; 67(4):2344-8. PubMed ID: 8383246
[TBL] [Abstract][Full Text] [Related]
17. Protection against feline immunodeficiency virus using replication defective proviral DNA vaccines with feline interleukin-12 and -18.
Dunham SP; Flynn JN; Rigby MA; Macdonald J; Bruce J; Cannon C; Golder MC; Hanlon L; Harbour DA; Mackay NA; Spibey N; Jarrett O; Neil JC
Vaccine; 2002 Feb; 20(11-12):1483-96. PubMed ID: 11858854
[TBL] [Abstract][Full Text] [Related]
18. Perspectives on FIV vaccine development.
Elyar JS; Tellier MC; Soos JM; Yamamoto JK
Vaccine; 1997; 15(12-13):1437-44. PubMed ID: 9302758
[TBL] [Abstract][Full Text] [Related]
19. Deluge of questions prompts AAFP to develop FIV vaccine brief. American Association of Feline Practitioners.
Kahler SC;
J Am Vet Med Assoc; 2002 Nov; 221(9):1231-4. PubMed ID: 12418682
[No Abstract] [Full Text] [Related]
20. Recombinant FeLV vaccine: long-term protection and effect on course and outcome of FIV infection.
Hofmann-Lehmann R; Holznagel E; Aubert A; Ossent P; Reinacher M; Lutz H
Vet Immunol Immunopathol; 1995 May; 46(1-2):127-37. PubMed ID: 7618252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
